Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States
- 2 June 2008
- Vol. 26 (23) , 2841-2848
- https://doi.org/10.1016/j.vaccine.2008.03.046
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Estimating Influenza Hospitalizations among ChildrenEmerging Infectious Diseases, 2012
- Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young ChildrenNew England Journal of Medicine, 2007
- Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract InfectionsThe Pediatric Infectious Disease Journal, 2006
- The Underrecognized Burden of Influenza in Young ChildrenNew England Journal of Medicine, 2006
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United StatesJAMA, 2003
- Illness Among Schoolchildren During Influenza SeasonArchives of Pediatrics & Adolescent Medicine, 2002
- The Japanese Experience with Vaccinating Schoolchildren against InfluenzaNew England Journal of Medicine, 2001
- Potential Cost Savings Attributable to Influenza Vaccination of School-aged ChildrenPublished by American Academy of Pediatrics (AAP) ,1999
- Health Impact of Influenza in the United StatesPharmacoEconomics, 1996
- Patterns of Shedding of Myxoviruses and Paramyxoviruses in ChildrenThe Journal of Infectious Diseases, 1981